E. Ayroldi et al., Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappa B, BLOOD, 98(3), 2001, pp. 743-753
Previously a novel gene was identified that encodes a glucocorticoid-induce
d leucine zipper (GILZ) whose expression is up-regulated by dexamethasone.
This study analyzed the role of GILZ in the control of T-cell activation an
d its possible interaction with nuclear factor kappaB (NF-kappaB). Results
indicate that GILZ inhibits both T-cell receptor (TCR)-induced interleukin-
2/interleukin-2 receptor expression and NF-kappaB activity. In particular,
GILZ inhibits NF-kappaB nuclear translocation and DNA binding due to a dire
ct protein-to-protein interaction of GILZ with the NF-kappaB subunits. More
over, GILZ-mediated modulation of TCR-induced responses is part of a circui
t because TCR triggering down-regulates GILZ expression. These results iden
tify a new molecular mechanism involved in the dexamethasone-induced regula
tion of NF-kappaB activity and T-cell activation. (C) 2001 by The American
Society of Hematology.